Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist.
Upadhyaya P, Lahdenranta J, Hurov K, Battula S, Dods R, Haines E, Kleyman M, Kristensson J, Kublin J, Lani R, Ma J, Mudd G, Repash E, Van Rietschoten K, Stephen T, You F, Harrison H, Chen L, McDonnell K, Brandish P, Keen N.
Upadhyaya P, et al.
J Immunother Cancer. 2021 Jan;9(1):e001762. doi: 10.1136/jitc-2020-001762.
J Immunother Cancer. 2021.
PMID: 33500260
Free PMC article.